Xcout Intel
Triana Biomedicines, Inc.
Triana Biomedicines, Inc. is a private biotechnology company focused on targeted molecular glue discovery. The company is headquartered in Lexington, Massachusetts.
Subscribe to see Triana Biomedicines, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Triana Biomedicines, Inc. at a glance
Triana Biomedicines, Inc. is a biotechnology company headquartered in United States. Its most recent funding round, Series B, raised $120M in December 2025. Xcout tracks 9 named people at Triana Biomedicines, Inc., including Patrick Trojer (President).
Triana Biomedicines, Inc. leadership
- Patrick TrojerPresident
- Caroline GermaChief Medical Officer
- Andrew HedinDirector
- Christopher O'DonnellDirector
- David GrayzelDirector
- Jigar RaythathaDirector
3 more named people on record for Triana Biomedicines, Inc., with roles, board committees and tenure — see the full roster →
Triana Biomedicines, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $120M | 11 named | |
| — | $110M | 11 named | |
| SEC Form D filing | $42.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Triana Biomedicines, Inc. competitors
A few of Triana Biomedicines, Inc.'s closest competitors — see the full list of competitors and alternatives →
KSQ Therapeutics, Inc. is a pharmaceutical manufacturing and biotechnology company located in Lexington, Massachusetts. The company focuses on drug discovery and development through its proprietary screening platform.
BridGene Biosciences, Inc. is a biotechnology company headquartered in San Jose, California, pioneering next-generation chemoproteomics through its IMTAC platform. The company is focused on discovering and developing innovative small molecule drugs for high-value targets.
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Photys Therapeutics, Inc. is a proximity-based biotechnology holding company founded in 2021 and headquartered in Massachusetts, United States. The company focuses on discovering and developing novel targeted protein therapeutics.
BIND Therapeutics, Inc. is a clinical-stage nanomedicine company headquartered in Cambridge, Massachusetts. The company specializes in developing targeted and programmable therapeutics using its proprietary platform to treat various diseases.
Get Triana Biomedicines, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Triana Biomedicines, Inc. in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access